Mutations of KCNJ2, encoding for the Kir2.1 potassium channel, and of ANKB, encoding for ankyrin B, can show the presence of clinical symptoms similar to CPVT. This evidence concerns the gene ANK2 and catecholaminergic polymorphic ventricular tachycardia.